Marco Di Tola1, Mariacatia Marino1, Simone Goetze1,2, Rossella Casale1, Sara Di Nardi1, Raffaele Borghini1, Giuseppe Donato3, Antonio Tiberti1, Antonio Picarelli4. 1. Department of Internal Medicine and Medical Specialties, Sapienza University, Polyclinic Umberto I, Viale del Policlinico, 155, 00161, Rome, Italy. 2. Klinikum Augsburg, Augsburg, Germany. 3. Department of Clinical Medicine, Sapienza University, Rome, Italy. 4. Department of Internal Medicine and Medical Specialties, Sapienza University, Polyclinic Umberto I, Viale del Policlinico, 155, 00161, Rome, Italy. antonio.picarelli@uniroma1.it.
Abstract
BACKGROUND: A celiac disease (CD) diagnosis is based on duodenal histology, with the exception of children showing anti-tissue transglutaminase (anti-tTG) serum levels exceeding ten times the cut-off. Our aim was to reproduce this simplified approach in adults, identifying an anti-tTG threshold value useful to diagnose CD without endoscopic procedures. METHODS: A total of 671 adult CD patients were subjected to blood sampling to determine anti-tTG serum levels, as well as to endoscopy with biopsy to perform duodenal histology. The anti-tTG serum levels/cut-off ratio was compared with the degree of duodenal lesions. RESULTS: Anti-tTG serum levels/cut-off ratio determined in patients with type IIIc was significantly higher than that measured in patients with type IIIb (p < 0.001), IIIa (p < 0.001), II (p < 0.05) and 0 (p < 0.001) of Marsh-Oberhuber histological classification. A significant correlation (r = 0.297, p < 0.0001) was found between the anti-tTG serum levels/cut-off ratio and the degree of duodenal lesions. The anti-tTG serum levels/cut-off ratio was classified as an accurate parameter (AUC = 0.715, p < 0.0001), with the best diagnostic performance obtained considering the threshold value >3.6 (sensitivity = 76.8 %, PPV = 97.2 %). CONCLUSIONS: The anti-tTG serum levels/cut-off ratio correlates with the degree of duodenal lesions and, if used with the threshold value >3.6, could avoid endoscopy with biopsy in about 75 % of seropositive adults waiting for CD diagnosis. However, since this procedure could also imply CD diagnosis in almost 3 % of seropositive patients with normal villous architecture, a consensus opinion is needed to suggest its use in the diagnosis of adult CD.
BACKGROUND:A celiac disease (CD) diagnosis is based on duodenal histology, with the exception of children showing anti-tissue transglutaminase (anti-tTG) serum levels exceeding ten times the cut-off. Our aim was to reproduce this simplified approach in adults, identifying an anti-tTG threshold value useful to diagnose CD without endoscopic procedures. METHODS: A total of 671 adult CD patients were subjected to blood sampling to determine anti-tTG serum levels, as well as to endoscopy with biopsy to perform duodenal histology. The anti-tTG serum levels/cut-off ratio was compared with the degree of duodenal lesions. RESULTS: Anti-tTG serum levels/cut-off ratio determined in patients with type IIIc was significantly higher than that measured in patients with type IIIb (p < 0.001), IIIa (p < 0.001), II (p < 0.05) and 0 (p < 0.001) of Marsh-Oberhuber histological classification. A significant correlation (r = 0.297, p < 0.0001) was found between the anti-tTG serum levels/cut-off ratio and the degree of duodenal lesions. The anti-tTG serum levels/cut-off ratio was classified as an accurate parameter (AUC = 0.715, p < 0.0001), with the best diagnostic performance obtained considering the threshold value >3.6 (sensitivity = 76.8 %, PPV = 97.2 %). CONCLUSIONS: The anti-tTG serum levels/cut-off ratio correlates with the degree of duodenal lesions and, if used with the threshold value >3.6, could avoid endoscopy with biopsy in about 75 % of seropositive adults waiting for CD diagnosis. However, since this procedure could also imply CD diagnosis in almost 3 % of seropositive patients with normal villous architecture, a consensus opinion is needed to suggest its use in the diagnosis of adult CD.
Entities:
Keywords:
Adult celiac disease; Anti-transglutaminase; Diagnosis; Duodenal lesions; Threshold value
Authors: A Tosco; R Aitoro; R Auricchio; D Ponticelli; E Miele; F Paparo; L Greco; R Troncone; M Maglio Journal: Clin Exp Immunol Date: 2013-01 Impact factor: 4.330
Authors: R Tortora; N Imperatore; P Capone; G D De Palma; G De Stefano; N Gerbino; N Caporaso; A Rispo Journal: Aliment Pharmacol Ther Date: 2014-09-28 Impact factor: 8.171
Authors: Ning Wang; Lennart Truedsson; Kerstin Elvin; Bengt A Andersson; Johan Rönnelid; Lucia Mincheva-Nilsson; Annica Lindkvist; Jonas F Ludvigsson; Lennart Hammarström; Charlotte Dahle Journal: PLoS One Date: 2014-04-07 Impact factor: 3.240
Authors: M Malamisura; R Colantuono; V M Salvati; R Croce; G D'Adamo; T Passaro; E D'Angelo; M Boffardi; A Garzi; B Malamisura Journal: Transl Med UniSa Date: 2019-01-12
Authors: Giuseppe Losurdo; Milena Di Leo; Edoardo Santamato; Monica Arena; Maria Rendina; Carmelo Luigiano; Enzo Ierardi; Alfredo Di Leo Journal: World J Gastroenterol Date: 2021-11-14 Impact factor: 5.742